<p>Evaluation of Urinary Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1 as Diagnostic Markers for Early Nephropathy in Patients with Type 2 Diabetes Mellitus</p>-Reference-Cited by-同舟云学术

Evaluation of Urinary Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1 as Diagnostic Markers for Early Nephropathy in Patients with Type 2 Diabetes Mellitus

Published:2020-06 Issue: Volume:Volume 13 Page:2199-2207
ISSN:1178-7007
Container-title:Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
language:en
Short-container-title:DMSO

Author:

Thuan Huynh Quang,Minh Pham Nguyet,Thao Pham Diep,Thi Hoang Minh,Phuong Thi Dam Lan^ORCID,Thi Ho Hang,Anh Phan Van,Thang Can Luong,Tuyet Mai Ngo Thi,Quy Dang Duy,Do Nhu Binh^ORCID,Thuan Nghiem Duc^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology,Internal Medicine

Reference43 articles.

1. Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective

2. Global trends in diabetes complications: a review of current evidence

3. The Global Burden of Diabetic Kidney Disease: Time Trends and Gender Gaps

4. Variations in Diabetes Prevalence in Low-, Middle-, and High-Income Countries: Results From the Prospective Urban and Rural Epidemiological Study

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous detection of multiple urinary biomarkers in patients with early-stage diabetic kidney disease using Luminex liquid suspension chip technology;Frontiers in Endocrinology;2024-08-20

2. Urinary biomarkers NG AL and beta-2 microglobulin in children with type 1 diabetes mellitus;Journal of Pediatric Endocrinology and Metabolism;2024-08-20

3. Phloretamide Protects against Diabetic Kidney Damage and Dysfunction in Diabetic Rats by Attenuating Hyperglycemia and Hyperlipidemia, Suppressing NF-κβ, and Upregulating Nrf2;Pharmaceutics;2024-04-07

4. Study of Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1 in Patients with Type 2 Diabetes Mellitus Nephropathy;Clinical Laboratory;2024

5. Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus;International Journal of Molecular Sciences;2023-12-12